for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Health News

Russia to complete early-stage trials on second COVID-19 vaccine on Sept. 30: RIA

MOSCOW (Reuters) - Russia will complete early-stage trials on a second potential COVID-19 vaccine produced by the Vector Institute on Sept. 30, the RIA news agency cited Russia’s consumer health safety watchdog as saying on Monday.

Reporting by Anton Kolodyzahnyy; writing by Tom Balmforth; editing by Mark Trevelyan

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up